Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WEITZEL, Jeffrey N")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

Screening-detected breast cancer in a man with BRCA2 mutation: Case reportBRENNER, R. James; WEITZEL, Jeffrey N; HANSEN, Nora et al.Radiology. 2004, Vol 230, Num 2, pp 553-555, issn 0033-8419, 3 p.Article

Genome-Wide Association Studies of CancerSTADLER, Zsofia K; THOM, Peter; ROBSON, Mark E et al.Journal of clinical oncology. 2010, Vol 28, Num 27, pp 4255-4267, issn 0732-183X, 13 p.Article

Comparison of Latina and Non-Latina White Women's Beliefs About Communicating Genetic Cancer Risk to RelativesMACDONALD, Deborah J; SARNA, Linda; GIGER, Joyce Newman et al.Journal of health communication. 2008, Vol 13, Num 5, pp 465-479, issn 1081-0730, 15 p.Article

Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research NetworkWEITZEL, Jeffrey N; CLAGUE, Jessica; SALVADOR SALDIVAR, J et al.Journal of clinical oncology. 2013, Vol 31, Num 2, pp 210-216, issn 0732-183X, 7 p.Article

Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriersWEITZEL, Jeffrey N; BUYS, Saundra S; SHERMAN, William H et al.Clinical cancer research. 2007, Vol 13, Num 2, pp 654-658, issn 1078-0432, 5 p., 1Article

A comparison of bilateral breast cancers in BRCA carriersWEITZEL, Jeffrey N; ROBSON, Mark; GHADIRIAN, Parviz et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 6, pp 1534-1538, issn 1055-9965, 5 p.Article

Reflex Immunohistochemistry and Microsatellite Instability Testing of Colorectal Tumors for Lynch Syndrome Among US Cancer Programs and Follow-Up of Abnormal ResultsBEAMER, Laura C; GRANT, Marcia L; ESPENSCHIED, Carin R et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1058-1063, issn 0732-183X, 6 p.Article

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialTUTT, Andrew; ROBSON, Mark; WARDLEY, Andrew et al.Lancet (British edition). 2010, Vol 376, Num 9737, pp 235-244, issn 0140-6736, 10 p.Article

Limited family structure and BRCA gene mutation status in single cases of breast cancer modeling genetic risk of breast cancer. CommentaryWEITZEL, Jeffrey N; LAGOS, Veronica I; OFFIT, Kenneth et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 23, issn 0098-7484, 2587-2595, 2637-2639 [12 p.]Article

Future Directions for Postdoctoral Training in Cancer Prevention: Insights from a Panel of ExpertsNELSON, David E; FAUPEL-BADGER, Jessica; FABIAN, Carol J et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 4, pp 679-683, issn 1055-9965, 5 p.Article

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortMASCIARI, Serena; DILLON, Deborah A; TELLI, Melinda et al.Breast cancer research and treatment. 2012, Vol 133, Num 3, pp 1125-1130, issn 0167-6806, 6 p.Article

Prevalence of BRCA mutations and founder effect in high-risk hispanic familiesWEITZEL, Jeffrey N; LAGOS, Veronica; BLAZER, Kathleen R et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 7, pp 1666-1671, issn 1055-9965, 6 p.Article

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. CommentaryWEITZEL, Jeffrey N; MCCAFFREY, Sarah M; NEDELCU, Raluca et al.Archives of surgery (Chicago, IL. 1960). 2003, Vol 138, Num 12, pp 1323-1329, issn 0004-0010, 7 p.Article

Quality of Cancer Family History and Referral for Genetic Counseling and Testing Among Oncology Practices: A Pilot Test of Quality Measures As Part of the American Society of Clinical Oncology Quality Oncology Practice InitiativeWOOD, Marie E; KADLUBEK, Pamela; PHAM, Trang H et al.Journal of clinical oncology. 2014, Vol 32, Num 8, pp 824-829, issn 0732-183X, 6 p.Article

Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation CarriersFINKELMAN, Brian S; RUBINSTEIN, Wendy S; OLOPADE, Olufunmilayo I et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1321-1328, issn 0732-183X, 8 p.Article

Variants of Uncertain Significance in Breast Cancer-Related Genes: Real-World Implications for a Clinical Conundrum. Part One: Clinical Genetics RecommendationsMILLER-SAMUEL, Susan; MCDONALD, Deborah J; MORRIS, Gloria J et al.Seminars in oncology. 2011, Vol 38, Num 4, pp 469-480, issn 0093-7754, 12 p.Article

Pathological characteristics of BRCA-associated breast cancers in HispanicsLAGOS-JARAMILLO, Veronica I; PRESS, Michael F; RICKER, Charite N et al.Breast cancer research and treatment. 2011, Vol 130, Num 1, pp 281-289, issn 0167-6806, 9 p.Article

Beyond Li Fraumeni Syndrome : Clinical Characteristics of Families With p53 Germline MutationsGONZALEZ, Kelly D; NOLTNER, Katie A; WEITZEL, Jeffrey N et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1250-1256, issn 0732-183X, 7 p.Article

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCULLINANE, Carey A; LUBINSKI, Jan; FRIEDMAN, Eitan et al.International journal of cancer. 2005, Vol 117, Num 6, pp 988-991, issn 0020-7136, 4 p.Article

Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 CarriersNEUHAUSEN, Susan L; BRUMMEL, Sean; GARBER, Judy E et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 8, pp 1690-1702, issn 1055-9965, 13 p.Article

Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting GenesREBBECK, Timothy R; MITRA, Nandita; OLOPADE, Olufunmilayo I et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 17, pp 5792-5805, issn 0008-5472, 14 p.Article

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityDOMCHEK, Susan M; FRIEBEL, Tara M; PICHERT, Gabriella et al.JAMA, the journal of the American Medical Association. 2010, Vol 304, Num 9, pp 967-975, issn 0098-7484, 9 p.Article

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trialAUDEH, M. William; CARMICHAEL, James; LU, n et al.Lancet (British edition). 2010, Vol 376, Num 9737, pp 245-251, issn 0140-6736, 7 p.Article

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk PredictionANTONIOU, Antonis C; BEESLEY, Jonathan; ISAACS, Claudine et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 23, pp 9742-9754, issn 0008-5472, 13 p.Article

Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation CarriersREBBECK, Timothy R; MITRA, Nandita; SINGER, Christian F et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 14, pp 5801-5810, issn 0008-5472, 10 p.Article

  • Page / 2